Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis.
A Group Kickboxing Program for Improving Balance, Mobility, and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study.
Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis.
Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum.
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.
Employment as a health promotion intervention for persons with multiple sclerosis.
Postural orthostatic tachycardia syndrome: additional phenotypic feature of neuromyelitis optica spectrum disorder.
Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity.
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
Modulation of B Cell Regulatory Molecules CD22 and CD72 in Myasthenia Gravis and Multiple Sclerosis.
Framework for Assessment of the Usability of Lower-Extremity Robotic Exoskeletal Orthoses.
Who receives rehabilitation in canadian long-term care facilities? A cross-sectional study.
Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.
Multiple Sclerosis: Risk Factors and Their Interactions.
Review of Animal Models of Neuromyelitis Optica.
Structure-activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201.
Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: an open label study.
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders.
Corrigendum.
Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies.
Suicide risk in multiple sclerosis: A systematic review of current literature.
Multiple sclerosis: Study in MS reveals impairments in 'theory of mind'
Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans.
Statistical normalization techniques for magnetic resonance imaging.
Pages
« first
‹ previous
…
280
281
282
283
284
285
286
287
288
…
next ›
last »